Analyst Ratings for First Tracks Biotherapeutics (TRAX)
TRAX Rating Summary
TRAX Price Target Summary
- Highest: $95.00 (Piper Sandler)
- Lowest: $30.00 (Wedbush)
- Average: $58.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$58.56 (+28.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | Wolfe Research | Andy Chen | New Coverage | Outperform (N/A) |
83.00 (N/A) |
43.60 (45.50) |
4.36% | Details |
| 6/8/2026 | Wells Fargo » Updated 7/28/2026 |
Derek Archila | New Coverage | Overweight (N/A) |
55.00 (30.00) |
18.20 (45.50) |
150% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
